BRIEF-GlaxoSmithKline announces unanimous FDA approval for Shingrix in over 50s

* FDA ADVISORY COMMITTEE VOTES UNANIMOUSLY FOR SHINGRIX (HZ/SU) IN US FOR PREVENTION OF HERPES ZOSTER (SHINGLES) IN ADULTS AGES 50 AND OVER​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Read more...
Positive 0 LOL 0 Interesting 0 Sad 0 Revolting 0 Fake 0

See also

Climate experts criticise Scotland's greenhouse emissions cuts strategy

Committee on Climate Change says policies needed to reach 2020 goal of 90% reduction are too weak and ill thought outClimate experts have warned the Scottish government its ambitious plans to cut greenhouse gas emissions lack credibility and risk stalling...

0 0